Denali Capital Acquisition Corp.

Status: Live Deal
U=S+W W=S@11.50
IPO Proceeds, $M $82.50M
IPO Date Apr 7, 2022
CEO Lei Huang
Left Lead Tiger Brokers
IPO Cash in Trust 102.0%
SPAC Tenor 12 + 3 + 3 + 9
IPO Sector General

Technology, consumer and hospitality (excluding China, Hong Kong, and Macau)

IPO Geography Global
Target Company Longevity Biomedical, Inc.
Deal Announced Jan 26, 2023
Deal Size, $M TBD
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Jan 9, 2024
Amendment Vote Oct 11, 2023
DECA DECAU DECAW

Sign up for Free Trial

No credit card required

Sign in for more on Denali Capital Acquisition Corp.:

  • Structure and cap table
  • 5 directors & officers
  • 36 filings and events
  • 4 underwriters
  • 1 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Lei Huang 51 CEO and Director
You ("Patrick") Sun 35 CFO
Jim Mao 54 Director
Kevin Vassily 56 Director
Huifeng Chang 56 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Tiger Brokers Joint BR 3,715,000 units
EF Hutton Joint BR 780,000
US Tiger Securities 3,000,000
Joseph Gunnar 5,000
7,500,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Filings

Sign in to view 36 filings.

Shareholders

Sign in to view shareholders 13F filing data.